Clominorex
Clominorex is a psychostimulant and anorectic drug that was patented and developed by the pharmaceutical company Yamanouchi Pharmaceutical. It is related to other anorectic agents such as fenfluramine and chlorphentermine.
History[edit]
Clominorex was first synthesized and patented in the 1960s by Yamanouchi Pharmaceutical. It was developed as a potential treatment for obesity due to its anorectic properties. However, it was never marketed and remains a largely obscure compound.
Pharmacology[edit]
Clominorex is a norepinephrine-dopamine reuptake inhibitor and releasing agent. It is structurally related to other anorectic agents such as fenfluramine and chlorphentermine, which are also norepinephrine-dopamine reuptake inhibitors. However, unlike these drugs, clominorex does not have any serotonin releasing activity.
Legal Status[edit]
Clominorex is not currently approved for medical use in any country. It is classified as a Schedule I controlled substance in the United States under the Controlled Substances Act, meaning it has a high potential for abuse and no accepted medical use.
See Also[edit]
References[edit]
